Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 1.727M
June 30, 2026 0.416M
March 31, 2026 -7.863M
December 31, 2025 -8.607M
September 30, 2025 -5.271M
June 30, 2025 -7.765M
March 31, 2025 -31.74M
December 31, 2024 -6.141M
September 30, 2024 -4.666M
June 30, 2024 -3.195M
March 31, 2024 -3.359M
December 31, 2023 -0.826M
September 30, 2023 -1.963M
June 30, 2023 -0.147M
Date Value
March 31, 2023 -2.134M
December 31, 2022 82.48M
September 30, 2022 0.132M
June 30, 2022 0.458M
March 31, 2022 -5.608M
December 31, 2021 284.37M
September 30, 2021 3.988M
June 30, 2021 -25.47M
March 31, 2021 662.50M
December 31, 2020 -5.037M
September 30, 2020 15.47M
June 30, 2020 -4.151M
March 31, 2020 -4.341M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Humana, Inc. -52.00M
Centene Corp. -584.00M
CVS Health Corp. -1.526B
UnitedHealth Group, Inc. -3.418B
Elevance Health, Inc. 838.00M